Page 46 - MBCA_FULL REPORT_FINAL_FOR_WEB
P. 46

Details of MBC Grants Dataset from 2000–2013
                                      Each record in the MBC Grants dataset was analyzed and assigned to 1 or more steps of
                                      metastasis. As shown in Figure 6, 815 grants (36%) were investigating aspects of invasion,
                                      670 (29%) were looking at metastatic colonization, 177 (8%) were studying intravasation and
                                      circulation, 47 (2%) focused on immune surveillance/escape, 26 (1%) were investigating arrest
                                      and extravasation, and 13 (1%) were studying metabolic deregulation. A total of 295 awards
                                      (13%) could not be categorized into a metastatic stage and were classified as “other”; and
                                      238 (10%) were classified into more than 1 metastatic stage. These percentages did not vary
                                      substantially from year to year from 2000 through 2013.



                                      Figure 6: Grants Categorized by Steps in Metastatic Process


             40%
                          invasion (815)


                                                       metastatic
                                                       colonization (670)
             30%





             20%
                                                                                             not relevant
                                                                                             other/not specified (295)
                                                                                  multiple
                                    intravasation                                 (238)
              10%                   & circulation (177)            metabolic
                                                                 deregulation
               5%                                                        (13)
             2.5%
              0%
                                          arrest &             immune
                                extravasation (26)             surveillance/escape (47)

















         46
   41   42   43   44   45   46   47   48   49   50   51